ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
CEND1 | Cell cycle exit and neuronal differentiation 1 | Predicted membrane proteins
| | | | | Tissue enriched |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
NRGN | Neurogranin (protein kinase C substrate, RC3) | | | | | | Tissue enriched |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enriched |
SHISA7 | Shisa family member 7 | Predicted membrane proteins
| | | | | Tissue enriched |
TMEM88B | Transmembrane protein 88B | Predicted membrane proteins
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
PGM2L1 | Phosphoglucomutase 2-like 1 | Enzymes
| | | | | Tissue enriched |
SCG3 | Secretogranin III | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINI1 | Serpin peptidase inhibitor, clade I (neuroserpin), member 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SH3GL2 | SH3-domain GRB2-like 2 | | | | | | Tissue enriched |
SMIM18 | Small integral membrane protein 18 | Predicted membrane proteins
| | | | | Tissue enriched |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CLEC2L | C-type lectin domain family 2, member L | Predicted membrane proteins
| | | | | Tissue enriched |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | Enzymes Plasma proteins
| | | | | Tissue enriched |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
DNM1 | Dynamin 1 | Enzymes Plasma proteins
| | | | | Tissue enriched |
FAM155A | Family with sequence similarity 155, member A | Predicted membrane proteins
| | | | | Tissue enriched |
GABRD | Gamma-aminobutyric acid (GABA) A receptor, delta | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
MAP1A | Microtubule-associated protein 1A | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
MT3 | Metallothionein 3 | | | | | | Tissue enriched |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | | | | | | Tissue enriched |
NPTXR | Neuronal pentraxin receptor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PEX5L | Peroxisomal biogenesis factor 5-like | | | | | | Tissue enriched |
SLC8A2 | Solute carrier family 8 (sodium/calcium exchanger), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SULT4A1 | Sulfotransferase family 4A, member 1 | | | | | | Tissue enriched |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SYT1 | Synaptotagmin I | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ANKRD34A | Ankyrin repeat domain 34A | | | | | | Tissue enriched |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | Predicted membrane proteins
| | | | | Tissue enriched |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
CELF5 | CUGBP, Elav-like family member 5 | | | | | | Tissue enriched |
GAD2 | Glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | Enzymes
| | | | | Tissue enriched |
GPR17 | G protein-coupled receptor 17 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
KIRREL3 | Kin of IRRE like 3 (Drosophila) | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
NAPB | N-ethylmaleimide-sensitive factor attachment protein, beta | | | | | | Tissue enriched |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
RAB3A | RAB3A, member RAS oncogene family | | | | | | Tissue enriched |
SOX8 | SRY (sex determining region Y)-box 8 | Transcription factors
| | | | | Tissue enriched |
ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | Predicted membrane proteins
| | | | | Tissue enriched |
STXBP1 | Syntaxin binding protein 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |